Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494477 · ClinicalTrials.gov registry record · NA

Evaluation of the Impact of the IN•Clued Curriculum: An LGBTQ Sex ed Program

A NA study of Teen Pregnancy and STD Prevention, sponsored by Philliber Research & Evaluation.

Completed
Registry status
NA
Development phase
1,401
Enrollment target
1
Study location

NCT04494477 is a NA study of Teen Pregnancy and STD Prevention that has completed, run by Philliber Research & Evaluation. The registered enrollment target is 1,401 participants, above the 1,235-participant average among 3 other Teen Pregnancy trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494477, a NA study of Teen Pregnancy and STD Prevention, has completed, sponsored by Philliber Research & Evaluation.

COMPLETED
Registry status
NA
Development phase
1,401 participants
Enrollment target
1
Study location

Study Summary

The INclued program was implemented in 16 states across the US. The purpose of this study is to measure: Nine months after the end of the program and one year after the workshop, are IN•clued participants less likely to report engaging in risky sexual behavior in the past three months compared to control group participants?

Interventions

  • BEHAVIORAL The IN•clued program

Study Locations (1)

New York

  • Philliber Research & Evaluation - Accord

Trial Details

FieldValue
Enrollment Target 1,401 participants
Start Date 2017-02-22
Est. Completion 2020-03-30
Phase NA

Sponsor

Philliber Research & Evaluation

3 total trials

What the Registry Record Tells You About NCT04494477

The ClinicalTrials.gov registry entry for NCT04494477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,401 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,235-participant average among 3 other Teen Pregnancy trials with a reported enrollment target (13% higher). The listed sponsor is Philliber Research & Evaluation, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Teen Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which The IN•clued program is the first listed.

NCT04494477 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04494477 about?

NCT04494477 is a clinical study titled "Evaluation of the Impact of the IN•Clued Curriculum: An LGBTQ Sex ed Program". The INclued program was implemented in 16 states across the US. The purpose of this study is to measure: Nine months after the end of the program and one year after the workshop, are IN•clued participants less likely to report engaging in risky sexual behavior in the past three months compared to co...

What is the current status of trial NCT04494477?

This trial is currently completed. It is a NA study. The enrollment target is 1,401 participants. The study started on 2017-02-22. Estimated completion is 2020-03-30.

What conditions does trial NCT04494477 study?

This clinical trial studies the following conditions: Teen Pregnancy, STD Prevention.

What interventions are being tested in trial NCT04494477?

The interventions under investigation include: The IN•clued program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04494477?

This trial is sponsored by Philliber Research & Evaluation, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494477 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Teen Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.